SC 13D Filing

Company

Aurinia Pharmaceuticals Inc.

Filed

September 12, 2024

Accession Number

0001214659-24-016381

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →